Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?

COX-2 as a target for cancer chemotherapy

(2014) Nilanjan Ghosh et al.   Pharmacological Reports

New trends for the medical treatment of endometriosis

(2012) Ana Luiza L Rocha et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?

(2011) J Geisler   BRITISH JOURNAL OF CANCER

Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

(2011) Maryam B. Lustberg et al.   Clinical Breast Cancer

The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis

(2011) Carla Olivares et al.   FERTILITY AND STERILITY

Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis

(2011) Analía Gabriela Ricci et al.   Reproductive Sciences

Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo

(2010) S. Banerjee et al.   CLINICAL CANCER RESEARCH

Prostaglandin E2: the master of endometriosis?

(2010) Meng-Hsing Wu et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model

(2010) Daniel Escorsim Machado et al.   FERTILITY AND STERILITY

The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis

(2010) Xiao-Qiu Wang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines

(2010) Claudia Bocca et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

(2009) C. Falandry et al.   ANNALS OF ONCOLOGY

Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women

(2009) Katherine E. Pelch et al.   FERTILITY AND STERILITY

Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis

(2009) Mariela Bilotas et al.   FERTILITY AND STERILITY

Inhibition of Cyclooxygenase-2 Down-regulates Aromatase Activity and Decreases Proliferation of Leydig Tumor Cells

(2009) Rosa Sirianni et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An overview on the expression of cyclooxygenase-2 in tumors of the head and neck

(2009) Rui Amaral Mendes et al.   ORAL ONCOLOGY

Endometriosis and Infertility

(2008) Sebiha Ozkan et al.   Annals of the New York Academy of Sciences

Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis

(2008) C. Olivares et al.   HUMAN REPRODUCTION

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib

(2008) Luc Yves Dirix et al.   JOURNAL OF CLINICAL ONCOLOGY

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer

(2008) Louis Wing-Cheong Chow et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms

(2007) S. K. Banu et al.   ENDOCRINOLOGY

Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis

(2007) Cleophas M. Kyama et al.   FERTILITY AND STERILITY